Coding, Coverage and Reimbursement

BOSTON—AdvaMed, the Medtech Association, brought together innovators and industry leaders at The MedTech Conference 2026, held October 18-21 in Boston. The conference recognized companies developing technologies to address a diverse array of patient needs through awards offered in several competitions and programs.

BOSTON—AdvaMed, the Medtech Association, convened the 13th Annual Symposium on Pediatric Device Innovation on October 18 at The MedTech Conference 2026 in Boston. In collaboration with the five U.S. Food and Drug Administration-funded Pediatric Device Consortia and with support from the Mussallem CHD Alliance, the symposium brought together innovators, clinicians, regulators, investors, and patient advocates to address the evidence and access barriers that keep promising technologies from reaching children.

WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the Medtech Association, welcomed the executive order from President Trump launching a new women’s health initiative, “Advancing Women’s Health to Improve Outcomes in All Phases of Life.” Whitaker made the following comment on the initiative.

BOSTON—AdvaMed, the Medtech Association, today announced Scott Garrett as the 2026 recipient of the AdvaMedDx Lifetime of Leadership & Service Award, honoring his more than 45 years of leadership across diagnostics, life sciences, medical products, specialty distribution, and laboratory services.

WASHINGTON, D.C.—AdvaMed®, the Medtech Association, today announced Vincent A. “Vince” Forlenza, former chairman and CEO of BD (Becton, Dickinson and Company), as the recipient of the 2026 AdvaMed Lifetime Achievement Award. Forlenza will receive the award during The MedTech Conference in Boston Oct. 18-21.

Explore how gaps in female inclusion in clinical research impact health outcomes, treatment guidelines, and medical device innovation — and what leading organizations are doing about it.

For people living with disabilities and chronic conditions, access to assistive technology can make the difference between dependence and independence. In this installment of AdvaMed’s Partners in Patient Care Q&A series, Peter W. Thomas, J.D., and Michael J. Barnett, J.D., Co-coordinators of the ITEM Coalition, discuss the communities they represent, the barriers patients face, and how collaboration with the medtech community can help improve patient access to assistive technology.

WASHINGTON, D.C.—AdvaMed, the Medtech Association, today recommended refinements the Centers for Medicare & Medicaid Services (CMS) could make to help its proposed Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway deliver more timely access to breakthrough medtech for Medicare beneficiaries.